Supraplase 40mg Injection
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Tenecteplase (40mg)
Overview Supraplase 40mg Injection
Cardiolyse 40mg Injection, a thrombolytic medication, is a critical treatment for acute myocardial infarction. Its mechanism involves dissolving clots obstructing coronary arteries. Administered intravenously by a physician immediately upon the onset of heart attack symptoms, close monitoring of vital signs (including respiration, blood pressure, and oxygen saturation) is essential. Concomitant anticoagulation therapy may be employed. Hemorrhage is the most frequent adverse effect, manifesting as injection site bleeding, epistaxis, hematochezia, hematuria, or gastrointestinal bleeding. Patients should exercise caution with sharp objects (e.g., razors, nail clippers) during treatment. This specialized injection requires expert administration and is contraindicated in numerous situations, such as recent head trauma, cerebrospinal surgery, or active bleeding. Comprehensive medical history review is mandatory before administration.
Uses of Supraplase 40mg Injection
Myocardial infarction
Major Benefits of Supraplase 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Supraplase 40mg Injection:
- Injection site bleeding
- Nosebleeds
- Blood in stool
- Blood in urine
- Gastrointestinal bleeding
How to use Supraplase 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Supraplase 40mg Injection works:
Thrombolytic agent Supraplase 40mg Injection breaks down damaging blood clots within blood vessels. This action facilitates the restoration of blood flow to compromised tissue, averting necrosis and improving patient prognosis.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Supraplase 40mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Supraplase 40mg Injection during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the treatment's advantages against possible risks prior to prescription. Physician consultation is advised.
Breast feedingCAUTION
Administering Supraplase 40mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingNOT RELEVANT
Irrelevant; Supraplase 40mg Injection is administered solely in the inpatient setting.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Supraplase 40mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Supraplase 40mg Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Supraplase 40mg Injection :
NA
Facts to Know About Supraplase 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Carboxylic Acid Derivatives |
| Developing Habits | No. |
| Treatment Category | Heart |
| Behavioral Class | Thrombolytic Agents: Plasminogen Activators |
3,018 People bought this recently